E-Learning Center
Join Our Network

Follow Imedex on Twitter

Register for an upcoming conference!

Phone: +1 (678) 242 0906

7th European Congress: Perspectives in Gynecologica Oncology

Register Now

7th European Congress:
Perspectives in Gynecologic Oncology

29-30 January 2010

W Barcelona Hotel

Barcelona, Spain

Who Should Attend

This educational activity is designed for gynecologists, oncologists, radiation therapists, pathologists, and other practitioners involved in the diagnosis and management of gynecologic cancers including ovarian, endometrial, and cervical cancers.



After successfully completing this educational activity, participants should be able to:

  • Assess the appropriate clinical usage of the human papilloma virus (HPV) vaccines in the prevention of cervical cancer and the role of preventative screening in the vaccination era
  • Apply advances in targeted therapy and surgical approaches to clinical practice for advanced and metastatic cervical cancer Determine ways to adequately manage cervical cancer in the pregnant patient
  • Summarize advances in and the role of adjuvant radiotherapy and chemotherapy in the management of endometrial cancer
  • Discuss recent clinical advances among uterine sarcomas and trophoblastic disease as they relate to the therapeutic management of these diseases
  • Determine the optimal surgical management of ovarian cancer as well as appropriate timing of second-line chemotherapy based on disease stage and clinical presentation
  • Discuss clinical data that may provide evidence to support new treatment options in ovarian cancer
  • Formulate the most favorable approach in the management of gynecological cancers by incorporating expert perspectives based upon emerging data

Frederic Amant, MD, PhD
University Hospitals Leuven
Leuven, Belgium

F. Xavier Bosch, MD, PhD, MPH
Catalan Institute of Oncology
Barcelona, Spain

Nicoletta Colombo, MD
University of Milan-Bicocca
Milan, Italy

Andreas du Bois, MD, PhD
HSK, Dr. Horst Schmidt Klinik
Wiesbaden, Germany

Michael J. Halaška, MD, PhD
Charles University
Prague, Czech Republic

Peter G. Harper, MD, FRCP
Guy’s and St Thomas’ Hospital
London, United Kingdom

Philipp Harter, MD
HSK, Dr. Horst Schmidt Klinik
Wiesbaden, Germany

Hermann Hertel, MD
Medical School Hannover
Hannover, Germany

Stanley B. Kaye, MD
The Royal Marsden Hospital
London, United Kingdom

Sean Kehoe, MD, FROCG
Oxford Radcliffe Hospital
St. Peters College University of Oxford
London, United Kingdom

Henry C. Kitchener, MD
University of Manchester
Manchester, United Kingdom

Fabrice Lécuru, MD, PhD
George Pompidou European Hospital
Paris, France

Andrea Mariani, MD
Mayo Clinic
Rochester, MN, United States

Jacobus Pfisterer, MD, PhD
Solingen, Germany

Eric Pujade-Lauraine, MD, PhD
Hôspital Hôtel-Dieu
Paris, France

Gordon J. S. Rustin, MD, FRCP
Mount Vernon Hospital
Northwood, United Kingdom

Michael J. Seckl, PhD, FRCP
Imperial College London
London, United Kingdom

Cristiana Sessa, MD, PhD
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Friday 29 January 2010

Welcome and introduction
Peter G. Harper, MD, FRCP

Session I: Cervical Cancer
Moderator: Peter G. Harper, MD, FRCP

HPV vaccination and implications for cervical cancer screening
F. Xavier Bosch, MD, PhD, MPH

Debate The role of surgical staging in operable cervical cancer
Moderator: Ignace Vergole, MD, MhD
Favors SLN: Fabrice Lécuru, MD, PhD
Opposes SLN: Hermann Hertel, MD

Targeted agents in cervical cancer: New drugs in the horizon
Cristiana Sessa, MD, PhD

Management of cervical cancer during pregnancy
Michael J. Halaška, MD, PhD


Session II: Endometrial Cancer
Moderator: Stanley B. Kaye, MD

Debate Are there still indications for lymphadenectomy – and if so, who should receive it?
Moderator: Andreas du Bois, MD, PhD
No indication: Henry C. Kitchener, MD
There is an indication: Andrea Mariani, MD

Adjuvant treatment of endometrial cancer
Ignace Vergote, MD, PhD

Update on the management of trophoblastic disease
Michael J.Seckl, PhD, FRCP

Sarcomas of the uterus
Frederic Amant, MD, PhD


Saturday 30 January 2010

Session III: Ovarian Neoplasm I
Moderator: Ignace Vergote, MD, PhD

Welcome and introduction

Debate This house believes that neoadjuvant therapy should become standard of care in ovarian cancer
Moderator: Stanley B. Kaye, MD
Pro: Sean Kehoe, MD, FROCG
Con: Jacobus Pfi sterer, MD, PhD

Management of borderline tumors
Andreas du Bois, MD, PhD


Management of hypersensitivity reactions to platinums and taxanes
Peter G. Harper, MD, FRCP

Keynote Address

Controversies in recurrent ovarian cancer: Role of CA125 and timing of 2nd-line chemotherapy
Gordon J.S. Rustin, MD, FRCP


Session IV: Ovarian Neoplasm II
Moderator: Andreas du Bois, MD, PhD

Case presentation and expert discussion
Management of a 9 month relapse patient
Non-platinum perspective: Nicoletta Colombo, MD
Platinum perspective: Eric Pujade-Lauraine, MD, PhD

Update on new treatment options in recurrent ovarian cancer
Stanley B. Kaye, MD

Selection of the right patients for surgery in recurrent ovarian cancer
Philipp Harter, MD

Closing remarks
Stanley B. Kaye, MD


Register Now

Discounted ............. €249
If payment is received by 24 November 2009

Regular ............. €349
If payment is received by 21 January 2010

Full/Onsite .......... €449
If payment is received after 21 January 2010

Nurses/Residents/Students* ........... €99
*proof of eligibility must accompany registration

To Register

You may register online by 21 January 2010 or by calling Imedex at +1 (678) 242 0906. Registration confi rmations will be issued before the Congress. To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.


To pre-register, registration and payment must be received no later than 21 January 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at to ensure the program is being held as scheduled and to confi rm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add €50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the Congress: 7th European Congress: Perspectives in Gynecologic Oncology A132.01. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Benefi ciary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29. Please note, only Euros will be accepted.

Registration Fee Inclusions: Registration fees include admittance to all scientifi c sessions, Congress materials, processing of certifi cates of attendance or continuing medical education, and all event functions as specified in the program.


For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than 21 January 2010. The amount of registration fees remitted, minus a €90 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 21 January 2010.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this Congress should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

W Barcelona
Placa de la Rosa dels Vents, 1
Final Passeig de Joan de Borbó
Barcelona, 08039 – Spain
Tel.: +34 (93) 295 2800
Fax : +34 (93) 181 5000
Website: http://www.starwoodmeeting.com/StarGroupsWeb/booking/reservation?id=0908286216&key=1A9BB

Where Miró meets the Mediterranean and medieval quarters showcase modernist masterpieces, W Barcelona is an avantgarde icon created by the world-famous Ricardo Bofi ll, rising above the spectacular beachfront in one of Europe’s most stylish cities.

Sail away in sensational style at W Barcelona, a stunning icon where 26 fl oors of signature W luxuries and pampering take you from the bustling boardwalks of the beachfront to the captivating colors of the Catalonian sky within a refl ecting facade of silvered glass. The hotel is a modernist masterpiece of avant-garde architecture anchoring the port’s Nova Bocana, where historic Barcelona meets the timeless Mediterranean Sea. From the doorstep, explore the vintage glam of La Barceloneta, the bustling fi sherman’s village leading to the Olympic Village’s beaches and water sports and Port Vell’s acclaimed restaurants via tree-lined esplanades. Or go the other way to Ciutat Vella, the Old City where gothic cathedrals, Roman foundations and Mediterranean mysteries come together in a vibrant maze of colorful neighborhoods and lively streets. From La Rambla, the city’s most famous promenade that’s also a fascinating installation of Barcelona’s most eclectic personalities and architecture, uncover every cobblestone of Barri Gòtic, the original old quarter, or browse La Ribera, where galleries and boutiques revolve around the Picasso Museum.

For the convenience of attendees, a limited number of rooms have been reserved until 7 January 2010 at a discounted rate of 199.00 single occupancy, plus tax (VAT), currently at 7%. This rate is not guaranteed outside the Congress dates or after 30 January 2010.

To reserve your room please contact the W Barcelona reservations department at +34 93 295 2800 or visit the hotel’s website at http://www.starwoodmeeting.com/StarGroupsWeb/booking/reservation?id=0908286216&key=1A9BB. To receive the group rate, callers must identify themselves as being with the 7th European Congress: Perspectives in Gynecologic Oncology group. Reservation requests received after 7 January 2010 may not be guaranteed the group rate.

Cancellation Policy:

  • All guest reservations will be done through Stargroups
  • Each guest will pay on their own
  • 15 days prior the event (12 January 2010) guests are 100% responsible in case of cancellation and W Barcelona can charge 100% of the reservation on guest’s personal credit card
  • Any individual cancellation on or before 27 December 2009 will be refunded in full to any individual guest
  • Any individual cancellation on or after 27 December 2009 will be charged 1 night cancellation fees to any individual guest
  • Any individual cancellation on or after 12 January 2010 will be non-refundable.

The 7th european congress: Perspectives in Gynecologic Oncology will be an international forum for attendees to share and enhance their knowledge on gynecologic cancers. Distinguished faculty and key opinion leaders will offer case-based discussion and practical approaches to the management of cervical, endometrial and ovarian cancers that can be applied to clinical practice.


Comments from past participants:

“Very good meeting, very relevant to my practice”

“Good balance of current and future approaches to patient care”

“Good content and format”

Italian Participants

Alijet & Fargo International SRL has been appointed as the official agency for government authorization for Italian participants. You may contact them directly at:
Alijet & Fargo International SRL
Via Pietro Maroncelli 44/66, 50137 Firenze, Italy
Tel.: +39 055 600 555
Fax: +39 055 609 078

The Registration and Information Desk will be staffed:
Friday, 29 January 2010 ............. 11:00 – 18:00
Saturday, 30 January 2010 ......... 08:00 – 15:30



PDF Save the Date



Andreas du Bois, MD, PhD
HSK, Dr. Horst-Schmidt-Klinik (HSK)
Wiesbaden, Germany

Peter G. Harper, MD, FRCP
Guy’s and St. Thomas’ Hospital
London, United Kingdom

Stanley B. Kaye, MD
The Royal Marsden Hospital
Sutton, United Kingdom

Ignace Vergote, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium



11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com


The following company is an exhibitor at this Congress:




Opportunities are available to companies interested in exhibiting at this conference. For more information, please contact Cori Gunter at +1(678) 242 0712, or by email at c.gunter@imedex.com.

Several options are available to companies interested in supporting this Congress.

For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.